-
Mashup Score: 0SGLT-2 Inhibitors: Potential Novel Strategy to Prevent Congestive Heart Failure in Diabetes? - Current Cardiovascular Risk Reports - 2 year(s) ago
Sodium-glucose transporter-2 (SGLT-2) inhibitors have emerged as novel oral glucose-lowering agents for type 2 diabetes. SGLT-2 inhibitors improve glycemic control by blocking sodium-glucose cotransport in the renal proximal tubules, thereby promoting glycosuria. In this review, it is discussed mechanistically how SGLT-2 inhibitors might be particularly relevant to use in patients with or at high…
Source: SpringerLinkCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3ESC 22: Hot Line & Late-breaking Science Video Collection - 2 year(s) ago
What’s hot at European Society of Cardiology (ESC) Congress 22? Stay tuned and browse our curated coverage of the latest data in cardiology. For a concise line up of the most
Source: www.ecrjournal.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 22Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications - 2 year(s) ago
AbstractAims. Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in left heart disease (LHD). This
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Pulmonary vascular disease (PVR >3WU) in patients with group 2 pulmonary hypertension associated with more severe lung congestion, right heart failure & poorer O2 delivery during #exercise. Our new paper from the #BarryBorlauglab: https://t.co/WJfMNIxcLA @yreddyhf @MassarOmard https://t.co/25v7dkRSST
-
-
Mashup Score: 4
Patients with HFpEF and normal NP display mild diastolic dysfunction and preserved CO reserve during exercise, despite marked elevation in filling pressures. While clinical outcomes are not as poor compared with patients with high NP, patients with normal NP HFpEF exhibit increased risk of death or …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
@HanCardiomd @WilfriedMullens @HFA_President @_antocannata @HillLoreena @ARakisheva @LauraMeems @ESC_Journals @escardio @gcfmd @AShchendrygina @BSHeartFailure @DrMarthaGulati @pabeda1 @KoushikReddyMD And #NatriureticPeptides may trick you here! Normal NTproBNP with still clinically relevant #HF https://t.co/aohjQmPiqK
-
-
Mashup Score: 10Heart failure with normal natriuretic peptide levels: more fat, and that is the main problem - 3 year(s) ago
This commentary refers to ‘Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbid
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 8
AbstractBackground. A substantial proportion of patients with heart failure (HF) with preserved ejection fraction (HFpEF) present with normal natriuretic peptid
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Detection of Left Atrial Myopathy Using Artificial Intelligence–Enabled Electrocardiography - 3 year(s) ago
Background: Left atrial (LA) myopathy is common in patients with heart failure and preserved ejection fraction and leads to the development of atrial fibrillation (AF). We investigated whether the li
Source: Circulation: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
An AI-enabled ECG acquired during normal sinus rhythm permits identification at point of care of individuals with atrial fibrillation.
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 5The First HFA Clinical Practice Update Course on Heart Failure - 3 year(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6The First HFA Clinical Practice Update Course on Heart Failure - 3 year(s) ago
Home Faculty Programme Main Hall Online: 25 – 26 November 2021 You must be…
Source: courses.escwebinars.orgCategories: Cardiologists, Latest HeadlinesTweet
@bmorecardiology @drjohnm @escardio Btw, we found out about another medication working in the proximal tubules, suggesting its usefulness in #heartfailure https://t.co/utSV09Jro1 Still proud on this one, it was submitted 5 months before EMPA-REG!